Mettler Toledo's management structure, including Head of Business Development for the Americas, Advanced Technology Development, Head of Worldwide Sales for AutoChem and General Manager of two different units within the AutoChem SBU. He has strong experience in establishing distributors and sales channels in many parts of the world, including US, Asia-Pacific, Europe, Canada and Latin America. Prior to Mettler-Toledo, Jeff worked for Spectra-Tech (ASI, Applied Systems division), a developer of the original FTIR spectrometers for in-situ Reaction Monitoring. He also worked for BioRad Laboratories/Digilab Division in Cambridge, MA.
Jeff holds a PhD in Analytical Chemistry from University of Georgia, Athens, Georgia and BS in Chemistry from Shippensburg University of Pennsylvania, Shippensburg, PA. His PhD thesis was based on the use of FTIR spectroscopy and Chemometric methods for analytical chemistry applications.
About Block Engineering:
Founded in 1956, Block Engineering is a leading developer of high performance Quantum Cascade Laser (QCL) and FTIR spectrometers for chemical detection and analysis to military, government, commercial, and industrial customers. Block's Mobile Chemical Agent Detector (MCAD) system, a fixed site, passive FTIR spectrometer offered in partnership with Northrop Grumman Corp., and PORTHOS™, a portable, passive FTIR spectrometer system, remotely detect chemical threats as far as 3 miles and protect against chemical warfare agents and weapons of mass destruction. Following the success of those products, Block has applied its extensive knowledge of spectroscopy and chemical detection towards the commercialization of its high performance QCL based spectrometers, such as the LaserScan™ Analyzer. In addition, Block is developing a revolutionary MEMS-based, miniaturized spectrometer, the ChemPen™, which is a low cost, FTIR chemical gas detector the size of a fountain pen.
Block Engineering, LLC is he
Page: 1 2 3 Related biology technology :1
|SOURCE Block Engineering, LLC|
Copyright©2010 PR Newswire.
All rights reserved
. Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer2
. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients3
. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development4
. GM Exec Joins Bio-Reaction Industries Board of Directors5
. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters6
. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs7
. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors8
. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines9
. Charles C. Harwood, Jr., Joins Cellectar, Inc.s Board of Directors10
. Chief Technology Officer Joins ACAMP11
. Mark Sutherland Joins GenVault as Senior Vice President, Business Development